Consumer Wearable Neurotechnology for Attention-Deficit/Hyperactivity Disorder: Evidence, Classification and Clinical Implications

Authors

• Christine Shawn Wade, University of LynchburgFollow

Specialty

PA Education, Extreme Medicine, Emergency & Disaster Management, Wilderness Medicine

Advisor

Dr. Blake Rogers

Abstract

ABSTRACT

PURPOSE: The purpose is to clarify terminology used in neurotechnology interventions, define Consumer Wearable Neurotechnology (CWNT), evaluate current evidence supporting CWNT systems in attention-deficit/hyperactivity disorder (ADHD), and assess their potential to improve executive function, support ADHD symptom management, and enhance quality of life.

METHODS: A structured narrative review of peer-reviewed studies published between 2021 and 2026 was conducted using PubMed, Embase, Cochrane, and PsycINFO. Randomized controlled trials, systematic reviews, and meta-analyses evaluating neurofeedback and emerging consumer wearable neurotechnology interventions for ADHD were prioritized. Evidence was evaluated with attention to executive function outcomes and real-world ADHD symptom measures.

RESULTS: Traditional EEG-based neurofeedback demonstrates modest improvements in structured, laboratory-based attention and executive function measures, with less consistent effects on blinded behavioral symptom ratings. Emerging Consumer Wearable Neurotechnology (CWNT) platforms integrate wearable electroencephalography (EEG)-derived engagement metrics into structured brain-activity–responsive cognitive training environments and demonstrate preliminary improvements in attention and executive function performance during training tasks. However, product-specific randomized evidence remains limited, and translation of these improvements into consistent, real-world ADHD symptom improvement remains uncertain.

CONCLUSION: Consumer Wearable Neurotechnology (CWNT) refers to wearable EEG-based systems that integrate brain-activity–responsive feedback into software-based cognitive training tasks. Current evidence suggests improvement in executive function performance during structured training; however, consistent translation into meaningful real-world ADHD symptom improvement remains uncertain. CWNT systems should not replace established pharmacologic or behavioral therapies. Clear terminology, realistic patient counseling, and continued product-specific research are essential for responsible clinical integration. CWNT systems may serve as adjunctive tools when used within appropriate clinical context and expectations.

Key words: Attention-Deficit/Hyperactivity Disorder; Consumer Wearable Neurotechnology; Computerized Cognitive Training; Neurofeedback; Executive Function; Digital Therapeutics

Recommended Citation

Wade CS. Consumer Wearable Neurotechnology for Attention-Deficit/Hyperactivity Disorder: Evidence, Classification and Clinical Implications. University of Lynchburg DMSc Doctoral Project Assignment Repository. 2026; 8(1).